Time Inc. has four options: Sell itself, sell some magazines, take a private investment... or do nothing at all. It's decision time for the iconic magazine publisher, whose board is evaluating bids this week. Time's digital advertising growth is promising, but shareholders may be hoping for a sale, says Bloomberg Gadfly columnist Tara Lachapelle and Americas telecommunications and media industry Team Leader Crayton Harrison.

Time Inc. has four options: Sell itself, sell some magazines, take a private investment... or do nothing at all. It's decision time for the iconic magazine publisher, whose board is evaluating bids this week. Time's digital advertising growth is promising, but shareholders may be hoping for a sale, says Bloomberg Gadfly columnist Tara Lachapelle and Americas telecommunications and media industry Team Leader Crayton Harrison.

Bloomberg M&A reporters, joined by outside experts and members of Bloomberg's Deals team, examines the week's biggest deals and highlights M&A trends most under scrutiny by Wall Street. He'll talk to reporters who broke Bloomberg's major scoops and interview investors, executives, lawyers and bankers for an inside peek into what's going on inside corporate boardrooms and what it's like working with the world's largest companies and richest people.

Bloomberg M&A reporter Alex Sherman examines the week's biggest deals and highlights M&A trends most under scrutiny by Wall Street.

Deal of the Week

Time’s Up at Time Inc. as Board Ponders Bids

Time's Up at Time Inc. as Board Ponders Bids

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/f89839e9-bb51-43f1-9445-ae39004e30b0/transcript

A few decades ago, nobody really questioned vaccines. They were viewed as a standard part of staying healthy and safe. Today, the number of people questioning vaccines risks prolonging a pandemic that has already killed hundreds of thousands of Americans. How we got to this moment didn’t start with the rollout of vaccines or in March 2020, or even with the election of Donald Trump. Our confidence in vaccines, often isn't even about vaccines. It’s about trust. And that trust has been eroding for a long time. Doubt, a new series from Bloomberg’s Prognosis podcast, looks at the forces that have been breaking down that trust. We'll trace the rise of vaccine skepticism in America to show how we got here — and where we’re going. Doubt launches on March 23. Subscribe to Prognosis today on Apple Podcasts, Spotify or wherever you get your podcasts.

A few decades ago, nobody really questioned vaccines. They were viewed as a standard part of staying healthy and safe. Today, the number of people questioning vaccines risks prolonging a pandemic that has already killed hundreds of thousands of Americans. How we got to this moment didn’t start with the rollout of vaccines or in March 2020, or even with the election of Donald Trump. Our confidence in vaccines, often isn't even about vaccines. It’s about trust. And that trust has been eroding for a long time. Doubt, a new series from Bloomberg’s Prognosis podcast, looks at the forces that have been breaking down that trust. We'll trace the rise of vaccine skepticism in America to show how we got here — and where we’re going. Doubt launches on March 23. Subscribe to Prognosis today on Apple Podcasts, Spotify or wherever you get your podcasts.

Introducing: Doubt

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/fc0b7b28-08e4-4e66-8a75-ae390045f3d2/transcript

The killers of Berta Caceres had every reason to believe they’d get away with murder. More than 100 other environmental activists in Honduras had been killed in the previous five years, yet almost no one had been punished for the crimes. Bloomberg’s Blood River follows a four-year quest to find her killers – a twisting trail that leads into the country’s circles of power.

Blood River is out now.

The killers of Berta Caceres had every reason to believe they’d get away with murder. More than 100 other environmental activists in Honduras had been killed in the previous five years, yet almost no one had been punished for the crimes. Bloomberg’s Blood River follows a four-year quest to find her killers – a twisting trail that leads into the country’s circles of power.Blood River is out now.

Introducing: Blood River

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/da172c4f-4b3a-4530-8c45-ae390045f461/transcript

On this new show from Bloomberg, hosts Mike Regan and Sarah Ponczek speak with expert guests each week about the main themes influencing global markets. They explore everything from stocks to bonds to currencies and commodities, and how each asset class affects trading in the others. Whether you’re a financial professional or just a curious retirement saver, What Goes Up keeps you apprised of the latest buzz on Wall Street and what the wildest movements in markets will mean for your investments. 

On this new show from Bloomberg, hosts Mike Regan and Sarah Ponczek speak with expert guests each week about the main themes influencing global markets. They explore everything from stocks to bonds to currencies and commodities, and how each asset class affects trading in the others. Whether you’re a financial professional or just a curious retirement saver, What Goes Up keeps you apprised of the latest buzz on Wall Street and what the wildest movements in markets will mean for your investments.

Introducing "What Goes Up," A New Show From Bloomberg

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/4844b49d-ed0c-4f5e-89ab-ae390045f3df/transcript

Time's Up at Time Inc. as Board Ponders Bids

In 1 playlist(s)

Deal of the Week

Social links

Follow podcast

Recent clips